Commonwealth Fusion Systems привлекла $1 млрд: всего $4 млрд на термояд для эпохи ИИ

Commonwealth Fusion Systems (CFS) from Massachusetts closed a new $1 billion round in July 2026, bringing total funding to $4 billion — according to the company itself, this represents approximately 30% of all global money invested in fusion energy. At the same time, CFS hired a banker who previously led Moderna's IPO, which the industry views as a clear signal of preparation for a public offering.

Why the AI boom turned fusion into a hot bet

For decades, fusion energy was the subject of the same old joke: the technology was called "always 30 years away" — a promise that never materialized. But the explosive growth of artificial intelligence has changed the equation. As TNW notes in its coverage of the CFS round, the AI boom is generating colossal demand for electricity — and that is precisely what has turned fusion into one of the hottest bets in technology.

Data centers serving large language models and agentic systems consume enormous amounts of power continuously — unlike manufacturing plants that can be shut down at night. Solar and wind generation is intermittent. Building traditional nuclear plants takes decades. Fusion, if commercialized, promises virtually unlimited clean baseload power with no long-lived radioactive waste — and it is exactly this combination that is attracting investors who previously never looked toward plasma physics.

$4 billion: why this figure is unusual for the industry

The scale of CFS's funding is unusual even by the standards of the most capital-intensive technology sectors:

• Total funding since founding: $4 billion
• Share of all global investment in fusion energy: ~30%
• Most recent closed round: $1 billion
• Headquarters: Massachusetts, USA

"The round brings the total amount raised to $4 billion — approximately 30% of all money invested in fusion energy," states the official

Commonwealth Fusion Systems announcement.

A single player controlling roughly one-third of all industry funding is a rare and telling situation. The market is not distributing bets evenly among dozens of startups: it is consolidating capital around a leader. This is a sign that investors are betting on a specific technological approach and a specific team — rather than building a broad thematic spread. This kind of concentration is typical of industries where the winner takes all.

Why hire the banker who took Moderna public

Commonwealth Fusion Systems has brought on a specialist who led Moderna's IPO — one of the most high-profile public offerings in biotech history. As TNW reports, such a move is generally seen as standard preparation for entering the public market: experienced IPO bankers typically join a company one to one-and-a-half years before an anticipated listing.

The choice of a specialist with Moderna's track record is symbolic. Moderna went public long before its product — mRNA vaccines — became commercially successful: the market was financing the technology's potential, not current revenues. CFS, it appears, is counting on the same logic. The company's fusion reactor is not yet generating commercial energy — but the IPO team's job is to convince the public market that it will one day do so at industrial scale.

What this means

Commonwealth Fusion Systems — the best-funded participant in the fusion race — is consistently moving toward an IPO. $4 billion in private investment and the arrival of a banker with Moderna's credentials are two clear signs of the company's transition from "promising startup" to "preparing for the public market." For the AI industry, which urgently needs scalable clean baseload energy, CFS's success could become one of the decade's key infrastructure solutions.